GB Patent
GB9322014D0 — Improvements in and relating to carrier particles for use in dry powder inhalers
Assigned to Coordinated Drug Development Ltd · Expires 1993-12-15 · 32y expired
What this patent protects
Patent listed against Remodulin.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.